Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene. The ...

The global generic drugs market is predicted to increase from $491.67 billion in 2026 to approximately $762.48 billion by 2035, per a Precedence Research study. According to Precedence Research, the ...

Despite recent scrutiny by the Food and Drug Administration regarding India’s drug manufacturing practices, the country’s drug industry has grown in recent years and continues to act as a large ...

Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 percent of all prescriptions filled in the United States yet accounted for only ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Chicago-based Xeris Biopharma has hauled two generic rivals into federal court, filing suit on Tuesday to stop would-be ...

Brand name drug companies use many tactics to prevent generic competition from hitting the market, according to Erin Fox, PharmD, director of Drug Information at University of Utah Health in Salt Lake ...

The value of the country’s generic medicine market is expected to reach over P400 billion by 2030, amid rising health care ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.